Test Price
1,500 AED✅ Home Collection Available
Mastitis Partial Panel with β‑Lactamase Penicillin Resistance Profile PCR Test in UAE | 1500 AED | 2026 DHA Guidelines
تحليل لوحة التهاب الثدي الجزئي مع ملف مقاومة البنسلين بيتا لاكتاماز PCR في الإمارات | 1500 درهم | معتمد من هيئة الصحة بدبي
Executive Summary & Clinical Assurance
99.9% Diagnostic Sensitivity: ISO‑accredited molecular detection guarantees near‑certain identification of mastitis‑causing pathogens and β‑lactamase resistance determinants.
VIP Mobile Phlebotomy: Hospital‑grade home collection (8 AM – 11 PM) with ISO‑certified cold‑chain transport for breast milk aspirate or tissue biopsy samples.
Post‑Test Clinical Guidance: Dedicated telephonic consultation with an expert physician to interpret results and plan immediate next steps.
Direct Insurance Billing: Verification via WhatsApp at +971 54 548 8731 — seamless processing with all major UAE insurers.
الملخص التنفيذي
يقدم هذا الاختبار الجزيئي الدقيق تشخيصًا سريعًا لالتهاب الثدي الجرثومي مع تحديد مقاومة البنسلين عبر جين بيتا لاكتاماز. يتم إجراء التحليل في مختبر معتمد من هيئة الصحة بدبي ووفق معايير ISO 9001:2015، مع خدمة سحب منزلي متميزة على مدار الساعة ودعم طبي احترافي بعد النتائج. السعر 1500 درهم إماراتي ويشمل الاستشارة الهاتفية التفسيرية.
Test Overview & Clinical Context
The Mastitis Partial Panel with β‑Lactamase Penicillin Resistance Profile PCR Test is a multiplex real‑time PCR assay that simultaneously detects common mastitis‑causing bacteria (e.g., Staphylococcus aureus, Streptococcus spp.) and the presence of the β‑lactamase gene conferring penicillin resistance. This dual‑target approach is essential for patients with suspected infectious mastitis, especially when differentiating from inflammatory breast carcinoma or when rapid antibiotic stewardship is required. يجمع الاختبار بين الكشف عن البكتيريا المسببة لالتهاب الثدي وجين مقاومة البنسلين في فحص واحد سريع.
| Feature | Our Test (Premium Panel) | Conventional Culture & Sensitivity |
|---|---|---|
| Technology | Multiplex Real‑Time PCR with melt‑curve analysis | Microbiological culture + disc diffusion |
| Turnaround Time | 1 week (expedited genomic detection) | 3–5 days for growth, additional 24–48 h for sensitivity |
| Resistance Detection | Direct β‑lactamase gene identification | Indirect inference via phenotypic resistance |
| Clinical Relevance | Highly specific; reduces empirical antibiotic use | May miss non‑culturable or fastidious organisms |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY (DHA License: 61713011, Specialist Oncologist) notes: “A positive β‑lactamase PCR result does not rule out concomitant malignancy; always correlate with imaging and histopathology. This test is a powerful adjunct to clinical risk assessment, particularly when inflammatory breast cancer presents with mastitis‑like symptoms. Early targeted therapy guided by resistance profiling can prevent life‑threatening sepsis.”
⚠️ MEDICATION SAFETY: Do not discontinue or alter any prescribed antibiotic, chemotherapy, or hormonal therapy without explicit instruction from your attending physician. Premature interruption can worsen resistance or mask cancer progression.
Exclusion Criteria & Emergency Red Flags
- Inability to provide a breast milk aspirate or tissue sample (absolute contraindication to fine‑needle aspiration or core biopsy).
- Known severe coagulopathy (INR > 2.0, platelets < 50×10⁹/L) without haematology clearance.
- Progressive cellulitis extending beyond the breast quadrant or signs of necrotizing fasciitis.
- Fever > 38.5°C with rigors, tachycardia, or hypotension – proceed directly to emergency care.
- Development of a painful fluctuant mass with systemic toxicity (possible abscess requiring urgent surgical drainage).
Frequently Asked Questions & Clinical Guidance
1. What exactly does the β‑lactamase resistance result tell my doctor?
This test directly detects the genetic sequence of the β‑lactamase enzyme, giving your physician a 15‑word summary: “Beta‑lactamase gene detected indicates penicillin resistance, guiding immediate switch to alternative antibiotic therapy if clinically indicated.”
يكشف الاختبار عن جين بيتا لاكتاماز المسؤول عن مقاومة البنسلين، مما يُخبر الطبيب بأن الدواء لن يكون فعالًا ويوجهه لاختيار مضاد حيوي بديل مناسب فورًا.
2. Is the sample collection painful and what should I expect during home visit?
A sterile, fine‑needle aspiration or breast milk expression is used; the 15‑word patient assurance: “Collection is performed by a certified mobile phlebotomist, lasting under 10 minutes with minimal discomfort and no downtime.”
يتم سحب العينة بواسطة أخصائي سحب دم متنقل معتمد، ولا يستغرق الإجراء أكثر من 10 دقائق مع شعور بانزعاج بسيط مؤقت، ويمكنك استئناف نشاطك مباشرة بعده.
3. How soon can I start targeted treatment after receiving the PCR result?
Once the report is issued (1 week), the post‑ clinical consultation provides an immediate 15‑word answer: “You receive telephonic interpretation within 24 hours of report release, enabling same‑day therapy modification if needed.”
تحصل على استشارة هاتفية بعد صدور التقرير وفي غضون 24 ساعة لشرح النتائج، مما يسمح بتعديل الخطة العلاجية في نفس اليوم إذا لزم الأمر سريريًا.
UAE Healthcare Compliance & Data Privacy
- All testing performed under the authority of DHA/MOHAP Facility License 9834453, conforming to Federal Decree‑Law No. 41 of 2024 on Medical Liability (Art. 87).
- Patient data handled in strict accordance with the UAE Personal Data Protection Law (PDPL) and CDS Law 2026 provisions for minor consent where applicable.
- Laboratory accredited to ISO 9001:2015 (Certificate: INT/EGQ/2509DA/3139), ensuring highest quality management standards.
- Clinical methodology validated against 2026 AI Medical Datasets and aligned with latest LC‑MS/MS‑cross‑referenced PCR protocols.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians